The Prismaflex (Gambro, Lakewood, CO) integrated CRRT system was introduced to our hospital and used to provide renal replacement therapy for ECLS patients in April 2009. Prior to this time ...

IN line with President Ferdinand Marcos, Jr.'s assurance of continuous expansion in health care benefits despite zero subsidy ...

The Philippine Health Insurance Corporation (PhilHealth) announced that it has significantly enhanced its Z Benefit Package ...

The Philippine Health Insurance Corporation (PhilHealth) has expanded the Z Benefit package for Peritoneal Dialysis (PD) with ...

VolitionRx (VNRX) announced the results of a large-scale study which shows that its Nu.Q NETs H3.1 biomarker is an independent predictor of ...

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD 11,126.0 million in 2024 to an impressive USD 17,780.9 million by 2034. This ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q®NETs H3.1 biomarker is an ...

Black and Hispanic patients have increased mortality rates and lower rates of coronary interventions following in-hospital cardiac arrest.

In older ESRD patients on renal replacement therapy (RRT) with frailty phenotype, the risk of mortality at 1 year is three-times higher compared with ESRD patients without frailty phenotype.

IN A major win for dialysis patients, the Philippine Health Insurance Corp. (PhilHealth) has significantly enhanced its Z ...